Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Finasteride and dutasteride have limited use in feminising therapy and are not recommended for routine use.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Finasteride and dutasteride are not recommended for feminizing therapy due to limited effectiveness and potential risks.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Feminizing hormone therapy increases kidney filtration rate.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Estrogen therapy can help stabilize the hairline in transfeminine individuals.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Oestrogens are key for bone growth during puberty in both boys and girls.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Finasteride and minoxidil together promote hair growth better than either alone.